The groundbreaking rise of Viagra has consistently remained a example of pharmaceutical success, yet its position within the broader industry now triggers questions about future yields . Copycat versions are diminishing exclusivity , prompting anxieties that supporting companies closely tied to Viagra's once-dominant influence could be a speculativ